The International journal of health planning and management · 2026
Influenza and Human Papillomavirus Vaccine Utilisation in Vulnerable Urban Youth in Edmonton, Alberta, Canada.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deck Sarah, Jang Se Lim, Harris Rachel, Kolahdooz Fariba, Zakkar Moutasem, Sharma Sangita
Аннотация
INTRODUCTION: This project explores influenza and human papillomavirus (HPV) vaccine utilisation among a multi-ethnic group of youth (aged 11-23 years) in Edmonton, Alberta, Canada.
METHOD: Using a cross-sectional design and purposive sampling, influenza vaccine utilisation over 3 years was assessed via questionnaire. Female participants also reported on HPV vaccine utilisation. Multinomial logistic regression was used to explore the factors associated with vaccine utilisation.
RESULTS: In the project sample, 16.7% of males and 14.7% of females had received the influenza vaccine each year. The lowest rates of influenza vaccination were reported by African/Middle Eastern/Latin American youth (8.3%), Indigenous youth (10.8%), and youth > 18 years (12.6%). For the HPV vaccine, 61.1% of females reported having received all doses, while 21.9% were unvaccinated. Rates of HPV vaccine utilisation were lowest among females of Asian origin, females aged 18-23 years, and females residing in Canada for < 5 years.
DISCUSSION: Observed associations between age, ethnicity, and vaccine utilisation in this study highlight potential barriers and warrant further research to inform policymaking.
METHOD: Using a cross-sectional design and purposive sampling, influenza vaccine utilisation over 3 years was assessed via questionnaire. Female participants also reported on HPV vaccine utilisation. Multinomial logistic regression was used to explore the factors associated with vaccine utilisation.
RESULTS: In the project sample, 16.7% of males and 14.7% of females had received the influenza vaccine each year. The lowest rates of influenza vaccination were reported by African/Middle Eastern/Latin American youth (8.3%), Indigenous youth (10.8%), and youth > 18 years (12.6%). For the HPV vaccine, 61.1% of females reported having received all doses, while 21.9% were unvaccinated. Rates of HPV vaccine utilisation were lowest among females of Asian origin, females aged 18-23 years, and females residing in Canada for < 5 years.
DISCUSSION: Observed associations between age, ethnicity, and vaccine utilisation in this study highlight potential barriers and warrant further research to inform policymaking.